Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aerie Pharmaceuticals Inc (AERI)  
$15.25 0.00 (0.00%) as of 4:30 Fri 11/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 47,361,000
Market Cap: 722.26(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $15.25 - $15.25
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Aerie Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of ophthalmic therapies for the treatment of patients with eye diseases and conditions including open-angle glaucoma, dry eye, and diabetic macular edema. Rhopressa® is a once-daily eye drop designed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rocklatan® is a once-daily fixed-dose combination of Rhopressa® and latanoprost, a prescribed drug for the treatment of patients with open-angle glaucoma or ocular hypertension. Co. is developing AR-15512, an ophthalmic solution for the treatment of patients with dry eye disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 333
  Page 7 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gryska David W Director   –       •      –    2019-05-23 4 A $0.00 $0 D/D 1,750 1,750     -
   Mcgraw Benjamin F III Director   –       •      –    2019-05-23 4 A $0.00 $0 D/D 1,750 8,050     -
   Croarkin Richard Director   –       •      –    2019-05-23 4 A $0.00 $0 D/D 1,750 6,350     -
   Du Toit Michael Director   –       •      –    2019-05-23 4 A $0.00 $0 D/D 1,750 6,350     -
   Cagle Gerald D. Director   –       •      –    2019-05-23 4 A $0.00 $0 D/D 1,750 21,550     -
   Mitro Thomas A President and COO   •       –      –    2019-05-16 4 D $40.54 $95,066 D/D (2,345) 69,849     -
   Mitro Thomas A President and COO   •       –      –    2019-05-16 4 A $0.00 $0 D/D 13,559 72,194     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-05-16 4 D $40.54 $168,038 D/D (4,145) 171,381     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-05-16 4 A $0.00 $0 D/D 32,171 175,526     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-05-16 4 D $40.54 $94,134 D/D (2,322) 334,406     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-05-16 4 A $0.00 $0 D/D 13,559 336,728     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-04-12 4 D $41.89 $64,888 D/D (1,549) 323,169     -
   Mitro Thomas A President and COO   •       –      –    2019-04-12 4 D $41.89 $65,516 D/D (1,564) 58,635     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-04-12 4 D $41.89 $109,417 D/D (2,612) 143,355     -
   Mitro Thomas A President and COO   •       –      –    2019-02-25 4 D $40.18 $41,265 D/D (1,027) 60,199     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-02-25 4 D $40.18 $62,761 D/D (1,562) 145,967     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-02-25 4 D $40.18 $31,220 D/D (777) 324,718     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2019-02-25 4 D $40.18 $21,456 D/D (534) 101,511     -
   Mitro Thomas A President and COO   •       –      –    2019-02-24 4 D $40.04 $41,121 D/D (1,027) 61,226     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-02-24 4 D $40.04 $61,141 D/D (1,527) 147,529     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-02-24 4 D $40.04 $34,314 D/D (857) 325,495     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2019-02-24 4 D $40.04 $26,787 D/D (669) 102,045     -
   Mitro Thomas A President and COO   •       –      –    2019-02-23 4 D $40.04 $30,551 D/D (763) 62,253     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-02-23 4 D $40.04 $42,162 D/D (1,053) 149,056     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-02-23 4 D $40.04 $16,416 D/D (410) 326,352     -
  333 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us